salmeterol xinafoate has been researched along with Myocardial Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumgartner, RA; Donohue, JF; Goodwin, E; Grogan, DR; Hanania, NA; Hanrahan, JP; Sciarappa, KA | 1 |
| Dunn, NR; Freemantle, SN; Mann, RD; Martin, RM | 1 |
1 trial(s) available for salmeterol xinafoate and Myocardial Ischemia
| Article | Year |
|---|---|
Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance.
Topics: Albuterol; Arrhythmias, Cardiac; Bronchitis; Bronchodilator Agents; Ethanolamines; Female; Forced Expiratory Volume; Formoterol Fumarate; Humans; Ipratropium; Male; Middle Aged; Myocardial Ischemia; Nebulizers and Vaporizers; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections; Salmeterol Xinafoate; Tremor | 2008 |
1 other study(ies) available for salmeterol xinafoate and Myocardial Ischemia
| Article | Year |
|---|---|
Risk of non-fatal cardiac failure and ischaemic heart disease with long acting beta 2 agonists.
Topics: Adrenergic beta-Agonists; Adult; Adverse Drug Reaction Reporting Systems; Aged; Albuterol; Anti-Asthmatic Agents; Cardiomyopathy, Dilated; Cohort Studies; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Nedocromil; Risk; Salmeterol Xinafoate; Terbutaline; Time Factors | 1998 |